
The acquisition brings Gallant’s experimental stem cell treatments for chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Three dozen attorneys, lenders, accountants, brokers, consolidators, and consultants who are actively involved in buying and selling veterinary practices weigh in on the future of veterinary practice sales.
Ask the practice-sale experts
I surveyed 18 attorneys, lenders, accountants, brokers, consolidators, and consultants who are actively involved in buying and selling veterinary practices. They shared their opinions on issues relating to the future of the veterinary practice market. The results, while not statistically rigorous, are interesting. Read on for more.

